Systemic inflammation in Fabry disease: a longitudinal immuno-genetic analysis based on variant stratification

Inflammation in Fabry disease is not merely a consequence of substrate accumulation but an active and early driver of disease. Preliminary inflammatory phenotypes based on immune mechanisms may guide future personalized therapeutic strategies.

Authors

Institutions

Publication Details

Journal
Therapeutic Advances in Rare Disease
Published
2025-09-01
DOI
https://doi.org/10.1177/26330040251375498
Citations
1
Primary Topic
Lysosomal Storage Disorders Research
Type
article
Field-Weighted Citation Impact
1.16
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Systemic inflammation in Fabry disease: a longitudinal immuno-genetic analysis based on variant stratification

Haylen J Marín G, Miguel A. López-Garrido
1 citations
Therapeutic Advances in Rare Disease
Lysosomal Storage Disorders Research
1.16
article

Systemic inflammation in Fabry disease: a longitudinal immuno-genetic analysis based on variant stratification

Haylen J Marín G, Miguel A. López-Garrido
article en
1 citations

Abstract

Inflammation in Fabry disease is not merely a consequence of substrate accumulation but an active and early driver of disease. Preliminary inflammatory phenotypes based on immune mechanisms may guide future personalized therapeutic strategies.

Therapeutic Advances in Rare DiseaseVol. 6
Andalusian Health Service (ES), Hospital Universitario San Agustín (ES)
Openalex Percentile: Top 18%
Lysosomal Storage Disorders Research
1.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.